You have 9 free searches left this month | for more free features.

Hypopharynx

Showing 1 - 25 of 505

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head Neck Cancer Trial in Shijiazhuang (Delineation for organs at risks (OARs) in IMRT plan)

Not yet recruiting
  • Head and Neck Cancer
  • Delineation for organs at risks (OARs) in IMRT plan
  • Shijiazhuang, Hebei, China
    Department of Radiotherapy, Hebei Province Hospital of Chinese M
Sep 9, 2022

HNSCC, Head Neck Cancer, Oropharynx Cancer Trial in Groningen (blood draws)

Recruiting
  • HNSCC
  • +4 more
  • blood draws
  • Groningen, Netherlands
    University Medical Center Groningen (UMCG)
Aug 23, 2023

Oral Cavity Cancer, Oropharynx Cancer, Hypopharynx Cancer Trial in Tampa (ENHANCE Intervention)

Recruiting
  • Oral Cavity Cancer
  • +3 more
  • ENHANCE Intervention
  • Tampa, Florida
    Moffitt Cancer Center
Apr 4, 2023

Neck Cancer Trial in Moscow (Pembrolizumab)

Recruiting
  • Neck Cancer
  • Moscow, Russian Federation
  • +2 more
Sep 21, 2022

Laryngeal Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma Trial in

Not yet recruiting
  • Laryngeal Squamous Cell Carcinoma
  • +2 more
  • Sentinel lymph node biopsy guided selective elective neck irradiation
  • Standard elective neck irradiation
  • Amsterdam, Netherlands
  • +5 more
Aug 30, 2022

Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx Trial in Rotterdam (CRGD-ZW800-1)

Not yet recruiting
  • Squamous Cell Carcinoma of the Larynx
  • Squamous Cell Carcinoma of the Hypopharynx
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Feb 21, 2023

Malignant Tumor of Oropharynx Stage III, Malignant Tumor of Larynx Stage III, Malignant Tumor of Hypopharynx Stage III Trial in

Recruiting
  • Malignant Neoplasm of Oropharynx Stage III
  • +7 more
  • Escalated Dose
  • Standard Dose
  • Kolkata, West Bengal, India
    Tata Medical Centre
Dec 2, 2021

Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • +3 more
  • Eliminating RT to the elective neck
  • RT standard of care
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023

Surgery Site Fistula Trial in Toronto (ICG dye)

Recruiting
  • Surgery Site Fistula
  • ICG dye
  • Toronto, Ontario, Canada
    University Health Network
May 30, 2022

Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck, Oral Cavity Squamous Cell Carcinoma Trial in Nashville

Not yet recruiting
  • Head and Neck Cancer
  • +9 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 9, 2022

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

Withdrawn
  • Head and Neck Squamous Cell Carcinoma
  • +4 more
  • (no location specified)
Aug 1, 2022

Head Neck Cancer Trial in San Diego (Medpulser Electroporation with Bleomycin, Surgical Excision)

Terminated
  • Head Neck Cancer
  • Medpulser Electroporation with Bleomycin
  • Surgical Excision
  • San Diego, California
    Inovio Biomedical Corporation
Mar 2, 2022

Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Copenhagen (Liquid biopsy)

Recruiting
  • Head and Neck Cancer
  • +26 more
  • Liquid biopsy
  • Copenhagen, Region Hovedstaden, Denmark
    University Hospital of Copenhagen, Rigshospitalet
Sep 14, 2021

Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,

Recruiting
  • Head Neck Cancer
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health Sciences
Aug 8, 2022

Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Tumors Trial in Shanghai (chemo TP regimen combined with Toripalimab)

Recruiting
  • Laryngeal Cancer
  • +2 more
  • chemotherapy TP regimen combined with Toripalimab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 2, 2022

Oropharynx Squamous Cell Carcinoma, Larynx Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma Trial in Brussels

Recruiting
  • Oropharynx Squamous Cell Carcinoma
  • +3 more
  • IO102
  • IO103
  • Brussels, Belgium
    Cliniques Universitaires Saint-Luc
May 6, 2022

Head Neck Cancer Trial in Columbus (drug, radiation, procedure)

Terminated
  • Head and Neck Cancer
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 29, 2021

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,

Completed
  • Hypopharynx Squamous Cell Carcinoma
  • +2 more
  • Birmingham, West Midlands, United Kingdom
  • +5 more
Nov 9, 2022

Head Neck Cancer Trial in France (cisplatin, fluorouracil, radiation therapy)

Completed
  • Head and Neck Cancer
  • Lille, France
  • +10 more
Feb 19, 2021

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell

Terminated
  • Stage III Squamous Cell Carcinoma of the Hypopharynx
  • +11 more
  • cetuximab
  • +3 more
  • Newark, New Jersey
    New Jersey Medical School
Apr 19, 2021

Stage II-IVB Operable HNSCC Oral Cavity, Hypopharynx, Oropharynx Trial in Seoul (Durvalumab, durvalumab + tremelimumab)

Recruiting
  • Stage II-IVB Operable HNSCC Oral Cavity
  • +3 more
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Apr 22, 2021